Topical Gentamicin in the Management of Bart Syndrome: A Case Report. [PDF]
El Ghouti B +3 more
europepmc +1 more source
Development and Validation of a Six-Gene Signature of Myeloid Antigen Presentation Dysfunction Based on Single-Cell and Multi-Cohort Transcriptomics for Predicting Prognosis and Recurrence of Hepatocellular Carcinoma. [PDF]
Tan Y +5 more
europepmc +1 more source
Oral status and dental treatment needs in patients with Epidermolysis Bullosa - a cross-sectional study. [PDF]
Véliz S +3 more
europepmc +1 more source
Role of Organ-Specific Endothelial Cells in Melanoma Adhesion Patterns. [PDF]
Hamdan M +4 more
europepmc +1 more source
Japanese intractable and rare dermatologic diseases: From the official skin-centered nanbyo core to an illustrative mechanism-based framework. [PDF]
Han Y, Qin TG, Song P.
europepmc +1 more source
FDA approval of prademagene zamikeracel (Zevaskyn): advancing gene therapy for recessive dystrophic epidermolysis bullosa (RDEB) patients. [PDF]
Shahid SR +3 more
europepmc +1 more source
Identification of a long-term surviving human mesenchymal stromal cell subpopulation and implications for recessive dystrophic epidermolysis bullosa treatment. [PDF]
Bonnet des Claustres M +8 more
europepmc +1 more source
How far have we come? From understanding collagen disorders to advancing treatment strategies. [PDF]
Williamson J +3 more
europepmc +1 more source
Narrowing the Differential: A Unique Case of Dystrophic Epidermolysis Bullosa. [PDF]
Yacobucci L +3 more
europepmc +1 more source
Innovations in topical epidermolysis bullosa treatment: integrating advanced dressings, bioactive therapies and tissue-engineered skin. [PDF]
Marwah MK, Kaur K, Ahmad S, Cheema HCK.
europepmc +1 more source

